RUTH MCDONALD: Open Payments
NPI 1538173687 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,175 in 177 payments from 38 companies in 2025. Trend: 2023 $3,061 · 2024 $2,622 · 2025 $3,175
Food & beverage: $3,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $343 |
| Amgen Inc. | 21 | $340 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $325 |
| Novo Nordisk Inc | 12 | $283 |
| PFIZER INC. | 21 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $170 |
| AstraZeneca Pharmaceuticals LP | 5 | $163 |
| Lilly USA, LLC | 9 | $149 |
| Gilead Sciences, Inc. | 1 | $117 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
Products named: CAPLYTA, Ozempic, Kerendia, OTEZLA, VRAYLAR, REPATHA, FARXIGA, UBRELVY.
Industry payments across NY — which companies pay providers there.
